View Document Preview and Link Document Date: 2014-11-06 23:49:35 Open Document File Size: 362,34 KB Share Result on Facebook
Company QALYs Resources / Patient / Goodrich / Monogram Biosciences / Immune Deficiency Syndrome / / Country Australia / / Currency USD / / Event FDA Phase / / IndustryTerm HIV treatment / genotypic algorithms / treatment of HIV / clinical algorithm / healthcare resources / platform technology / draft decision analytic protocol / draft protocol / capital equipment / final protocol / tropism assay interpretation algorithms / / MedicalCondition HIV infection / Lancet Infectious Diseases / patient’s HIV infection / i.e. infection / HIV / viral infection / strain / HIV RNA / primary infection / initial infection / diseases / different opportunistic infections / infection / untreated infection / / MedicalTreatment antiretroviral treatment / Antiretroviral Therapy / immunosuppression / HAART / antiretroviral therapies / / Organization Pharmaceutical Benefits Advisory Committee / National Science Foundation / Therapeutic Goods Administration / Department of Health / Medical Services Advisory Committee / National Association of Testing Authorities / / Person Ageing / Lima / V / Van Der Ryst / / Position major capital cities / Governor / Minister / pathologist / Consultant / / Product efavirenz / zidovudine / CCR5 / lamivudine / / ProvinceOrState Montana / / Technology alpha / draft protocol / genotypic algorithms / clinical algorithm / draft decision analytic protocol / platform technology / genotypic HIV tropism assay interpretation algorithms / Genotype / final protocol / Consultation Decision Analytic Protocol / / URL http / SocialTag 
MSAC Application 1174: Consultation Decision Analytic Protocol (DAP) to guide the assessment of a pathology test to determine if a patient has been infected with CCR5 tropic